| 摘要 |
Glucopyranosyloxypyrazole derivatives represented by general formula (I), which have an effect of inhibiting human SGLT2 activity and are useful as preventives or remedies for diabetes, complication of diabetes or obesity, or pharmacologically acceptable salts thereof. In said formula, R1 representshydrogen or lower alkyl; one of Q1 and T1 represents a group of formula (A), while the other represents lower alkyl or halogenated lower alkyl; and R2 represents hydrogen, lower alkyl, lower alkoxy, lower alkylthio, halogenated lower alkyl or halogeno. (I) (A)
|
